Financhill
Back

Dyne Therapeutics Quote, Financials, Valuation and Earnings

America's Final Republican President

Click here to see his 2024 election prediction.
Buy
53

DYN
Dyne Therapeutics

Last Price:
25.82
Seasonality Move:
9.87%

7 Day Trial

ALL ACCESS PASS

$ 7

My #1 Coin is...

All the details are on the next page.

Dyne Therapeutics Price Quote

$25.82
+0.60 (+2.38%)
(Updated: May 1, 2024 at 6:55 PM ET)

Dyne Therapeutics Key Stats

Buy
53
Dyne Therapeutics (DYN) is a Buy

Day range:
$25.02 - $26.44
52-week range:
$6.40 - $30.27
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
22.64%

Volume:
469.3K
Avg. volume:
1000K
1-year change:
143.44%
Market cap:
$2.1B
Revenue:
$0
EPS:
$-3.94

How Much Does Dyne Therapeutics Make?

Data Unavailable

Is Dyne Therapeutics Growing As A Company?

Data Unavailable

Dyne Therapeutics Stock Price Performance

  • Did Dyne Therapeutics Stock Go Up Last Month?
    Dyne Therapeutics share price went down by -11.17% last month
  • Did DYN's Share Price Rise Over The Last Year?
    DYN share price rose by 143.44% over the past 1 year

What Is Dyne Therapeutics 52-Week High & Low?

Dyne Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Dyne Therapeutics?

  • How Much Debt Does Dyne Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Dyne Therapeutics Have?
    Cash and short term investments quarterly total is $123.1M
  • What Is Dyne Therapeutics’s Book Value Per Share?
    Book value per share is 1.49

Is Dyne Therapeutics Cash Flow Positive?

  • What Is DYN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$188.2M
  • What Is Dyne Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $54.3M
  • What Is Dyne Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $83.3M

Dyne Therapeutics Return On Invested Capital

Data Unavailable

Dyne Therapeutics Earnings Date & Stock Price

Dyne Therapeutics Competitors

  • Who Are Dyne Therapeutics's Competitors?
    Below is a list of companies who compete with Dyne Therapeutics or are related in some way:
    • CEL-SCI Corp (CVM)
    • Prime Medicine Inc (PRME)
    • Sana Biotechnology Inc (SANA)
    • Solid Biosciences Inc (SLDB)
    • Tenaya Therapeutics Inc (TNYA)

Dyne Therapeutics Dividend Yield

Data Unavailable

Dyne Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -17.15%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 37.80
Upside from Last Price: 49.88%

Major Shareholders

  • How many DYN shares are owned by institutional investors?
    84.6M DYN shares are owned by institutional investors
  • How many DYN shares are owned by insiders?
    2M DYN shares are owned by insiders